Advertisement AxoGen and LifeNet partner in nerve injury treatment - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

AxoGen and LifeNet partner in nerve injury treatment

AxoGen Nerve Regeneration has announced a strategic partnership with LifeNet Health, an allograft bio-implant company, for the processing of Avance Nerve Grafts.

Avance Nerve Graft is said to be the only off-the-shelf product available that gives surgeons the option to repair damaged peripheral nerves with human allograft nerve. Avance Nerve Graft allows surgeons to perform the typically preferred nerve-to-nerve repair while eliminating the need for a second donor site surgery.

Karen Zaderej, COO for AxoGen, said: “We are proud to partner with LifeNet Health in providing donor families another option for tissue donation. With this partnership, we will be able to reach even more patients in need of peripheral nerve repair to improve and restore their quality of life.”